RE: Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with -I-metaiodobenzylguanidine. Huibregtse K et al. European Journal of Cancer 2016. 66:144-152.
作者信息
Ronckers Cecile M, Tytgat Lieve, van den Heuvel-Eibrink Marry M, Teepen Jop, Kremer Leontine C M, Clement Sarah, van Santen Hanneke M
机构信息
Emma Children's Hospital/Academic Medical Center (AMC), Department of Pediatric Oncology, Amsterdam, The Netherlands; Dutch Childhood Oncology Group/Late Effects After Childhood Cancer (DCOG-LATER) Consortium, The Netherlands.
Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
出版信息
Eur J Cancer. 2017 May;77:21-23. doi: 10.1016/j.ejca.2017.02.019. Epub 2017 Mar 27.
PMID:28359832
Abstract
摘要
Zotero 插件